Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women

P T. 2017 Apr;42(4):237-241.

Abstract

Flibanserin (Addyi) for female sexual interest/arousal disorder in premenopausal women.